Advancements In Generative AI Models In Personalized Learning Trend: A Crucial Influence on the Pertussis Vaccine Market's Transformation in 2025

How Are the key drivers contributing to the expansion of the pertussis vaccine market?
The rise in birth rates contributes significantly to the expansion of the pertussis vaccine market. The term childbirth refers to the process of delivering a child, marking the termination of a pregnancy and the fetus's commencement of life outside the maternal womb. The pertussis vaccine helps shield newborns from the adverse effects of whooping cough and other severe, possibly life-threatening diseases. In January 2023, data published by the Centers for Disease Control and Prevention, a US-based national public health institution, revealed a 1% increase in recorded births from the preceding year, amounting to 3,664,292. Consequently, this escalation in birth rates fuels the enlargement of the pertussis vaccine market. The pertussis vaccine market is also set to grow due to a surge in the geriatric population. The term 'geriatric population' applies to the demographic comprising individuals aged 65 and above or in the twilight years of their lives. This demographic's growth represents a significant driving force for the pertussis vaccine market because as lifespans extend, so does the demand for the pertussis vaccine, which shields elderly individuals from this grave illness. Data from the World Health Organization, a Switzerland-based intergovernmental health organization, in October 2022 stated that the global population of individuals aged 60 and above would likely double by 2050 to 2.1 billion. Furthermore, there is a predicted tripling of the population aged 80 and above from 2020 to 2050, reaching 426 million. This growing elderly population thus fosters the expansion of the pertussis vaccine market.

Get Your Pertussis Vaccine Market Report Here:
https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

What growth opportunities are expected to drive the pertussis vaccine market's CAGR through 2034?
In recent times, there has been a consistent increment in the size of the pertussis vaccine market. The expansion trajectory shows a growth from $5.5 billion in 2024 to $5.72 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.1%. Factors such as prevalence of the disease, initiatives towards immunization, vaccination amongst children as well as regulatory approvals have contributed significantly to the growth observed in the historic periods.

The market size of the pertussis vaccine is predicted to experience constant growth in the upcoming years, reaching $6.62 billion in 2029 with a compound annual growth rate (CAGR) of 3.7%. The anticipated growth for the mentioned period can be linked to various factors like booster vaccination, maternal immunization, healthcare workers' immunization, and worldwide health initiatives. Key trends expected in this period comprise customized immunization schedules, combined vaccines, initiatives for vaccine equality, and the use of digital health for immunization.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

What are the emerging trends shaping the future of the pertussis vaccine market?
Key players in the pertussis vaccine market are pushing innovation and securing approvals to reinforce their market standing. For example, GSK plc., a pharmaceutical and biotechnology firm based in the UK, revealed in October 2022 that the U.S. Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine, comprised of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap), is deployed in pregnancy to fend off pertussis, or whooping cough, in newborns. The vaccine, which is administered once in the upper arm muscle, is both safe and effective for expectant mothers and their infants. Moreover, it efficiently guards against pertussis, even in its severe forms.

Which growth-oriented segments of the pertussis vaccine market are leading the industry's development?
The pertussis vaccine market covered in this report is segmented -

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine
3) By Application: Children, Adults, Infants
4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:
1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP
2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13023

What regions are leading the charge in the pertussis vaccine market?
North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What companies are at the forefront of innovation in the pertussis vaccine market?
Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

What Is Covered In The Pertussis Vaccine Global Market Report?

•Market Size Forecast: Examine the pertussis vaccine market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the pertussis vaccine market for a structured understanding.
•Key Players Overview: Analyze major players in the pertussis vaccine market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pertussis vaccine market.
•Segment Contributions: Evaluate how different segments drive overall growth in the pertussis vaccine market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pertussis vaccine market.
•Industry Challenges: Identify potential risks and obstacles affecting the pertussis vaccine market.
•Competitive Landscape: Review strategic developments in the pertussis vaccine market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.